Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Indian J Tuberc ; 64(4): 281-290, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28941850

RESUMO

BACKGROUND: Universal access to tuberculosis (TB) care services emphasizes early detection and initiation of treatment for all pulmonary TB patients. Pre-treatment loss to follow-up patients needs to be actively tracked and treated to break the chain of transmission in the community. OBJECTIVES: MATERIALS AND METHODS: A questionnaire based cross sectional study of a sample of 340 patients who were pre-treatment loss to follow-up was conducted from November 2011 to March 2012 in Delhi. Qualitative study involved focused group discussions with paramedical providers using a topic outline guide, patients were interviewed using semi-structured questionnaire and brainstorming of program managers to elicit reasons, suggestions and health seeking behavior among those who were pre-treatment loss to follow-up. RESULTS: Preference for private practitioners (64.4%), lack of trust in government health system (26.7%), inconvenient time of Directly Observed Treatment (DOT) centre (18.5%) and wrong patient address (14%) were the main reasons for pre-treatment loss to follow-up. Paramedical provider's opinion elicited in focused group discussion was that there is an increased tendency of pre-treatment loss to follow-up in drug addicts and home-less patients. Brainstorming with program managers revealed that a lack of trust in allopathic system of medicine and human resource constraints were the leading causes of pre-treatment loss to follow-up. A Meso level multi disciplinary model with community participation through Resident Welfare Associations (RWAs) has been designed based on the above findings. The model suggests mutual collaboration between government and non government agencies for promotion of International Standards of TB care in private clinics, de addiction services and social welfare schemes through RWAs. CONCLUSION: There is a need for Advocacy Communication and Social Mobilization on a large scale. Collaboration with Resident Welfare Associations (RWAs) and with practitioners from alternate systems of medicine should be encouraged.


Assuntos
Perda de Seguimento , Programas Nacionais de Saúde , Pacientes Desistentes do Tratamento , Tuberculose Pulmonar/tratamento farmacológico , Adolescente , Adulto , Estudos Transversais , Terapia Diretamente Observada , Feminino , Grupos Focais , Conhecimentos, Atitudes e Prática em Saúde , Acessibilidade aos Serviços de Saúde , Pessoas Mal Alojadas , Humanos , Índia , Entrevistas como Assunto , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde , Preferência do Paciente , Transtornos Relacionados ao Uso de Substâncias/complicações , Inquéritos e Questionários , Confiança , Tuberculose Pulmonar/complicações , Tuberculose Pulmonar/diagnóstico , Adulto Jovem
2.
Health Res Policy Syst ; 12: 3, 2014 Jan 17.
Artigo em Inglês | MEDLINE | ID: mdl-24438431

RESUMO

BACKGROUND: The key to universal coverage in tuberculosis (TB) management lies in community participation and empowerment of the population. Social infrastructure development generates social capital and addresses the crucial social determinants of TB, thereby improving program performance. Recently, there has been renewed interest in the concept of social infrastructure development for TB control in developing countries. This study aims to revive this concept and highlight the fact that documentation on ways to operationalize urban TB control is required from a holistic development perspective. Further, it explains how development of social infrastructure impacts health and development outcomes, especially with respect to TB in urban settings. METHODS: A wide range of published Government records pertaining to social development parameters and TB program surveillance, between 2001 and 2011 in Delhi, were studied. Social infrastructure development parameters like human development index along with other indicators reflecting patient profile and habitation in urban settings were selected as social determinants of TB. These include adult literacy rates, per capita income, net migration rates, percentage growth in slum population, and percentage of urban population living in one-room dwelling units. The impact of the Revised National Tuberculosis Control Program on TB incidence was assessed as an annual decline in new TB cases notified under the program. Univariate linear regression was employed to examine the interrelationship between social development parameters and TB program outcomes. RESULTS: The decade saw a significant growth in most of the social development parameters in the State. TB program performance showed 46% increment in lives saved among all types of TB cases per 100,000 population. The 7% reduction in new TB case notifications from the year 2001 to 2011, translates to a logarithmic decline of 5.4 new TB cases per 100,000 population. Except per capita income, literacy, and net migration rates, other social determinants showed significant correlation with decline in new TB cases per 100,000 population. CONCLUSIONS: Social infrastructure development leads to social capital generation which engenders positive growth in TB program outcomes. Strategies which promote social infrastructure development should find adequate weightage in the overall policy framework for urban TB control in developing countries.


Assuntos
Política de Saúde , Programas Nacionais de Saúde/organização & administração , Mudança Social , Tuberculose/prevenção & controle , Serviços Urbanos de Saúde/organização & administração , Educação/estatística & dados numéricos , Emigração e Imigração/estatística & dados numéricos , Política Ambiental , Feminino , Humanos , Incidência , Relações Interinstitucionais , Masculino , Fatores Socioeconômicos , Tuberculose/epidemiologia , Cobertura Universal do Seguro de Saúde , Saúde da População Urbana
3.
PLoS One ; 7(12): e51854, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23300568

RESUMO

SETTING: Six selected districts in Northern India. OBJECTIVES: To find out the trend in Annual risk of tuberculous infection (ARTI) in north India. STUDY DESIGN: Two rounds of community level surveys were conducted during 2000-2001 and 2009-10 respectively. Representative samples of children 1-9 years of age were tuberculin tested and maximum transverse diameter of induration was recorded in mm at about 72 hours. ARTI was computed from the estimated Prevalence of infection using mirror-image technique and anti-mode method. RESULTS: ARTI was found to decline from 1.9% (confidence interval: 1.7-2.1) at round I to 1.1% (confidence interval: 0.8-1.3) at round II at the rate of 8% per year during the intervening period. CONCLUSION: A significant reduction in the risk of tuberculous infection among children was observed between two rounds of surveys carried out at an interval of about 9 years.


Assuntos
Mycobacterium tuberculosis/patogenicidade , Tuberculose/etiologia , Vacina BCG/uso terapêutico , Criança , Pré-Escolar , Feminino , Humanos , Índia/epidemiologia , Lactente , Masculino , Vigilância da População , Prevalência , Medição de Risco , Tuberculose/epidemiologia , Tuberculose/prevenção & controle
4.
Indian J Tuberc ; 56(2): 77-81, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19810589

RESUMO

OBJECTIVES: To study the impact of Revised National TB Control Programme on mortality among tuberculosis patients in Delhi and to correlate mortality trends with programme indicators. METHODS: Record based evaluation of mortality trends from TB registers of all chest clinics of Delhi after implementation of Revised National TB Control Programme. RESULTS: The study showed a statistically significant decline in tuberculosis mortality among new smear positive cases after the implementation of Revised National TB Control Programme (z = 4.478 p < 0.05). The mortality among new smear negative and extra pulmonary cases also showed reduction, though not statistically significant. CONCLUSION: Mortality due to tuberculosis has been considerably reduced in Delhi over the years with the Revised National TB Control Programme implementation since 1997.


Assuntos
Controle de Doenças Transmissíveis/métodos , Programas Nacionais de Saúde , Tuberculose/mortalidade , População Urbana , Terapia Diretamente Observada/métodos , Humanos , Índia/epidemiologia , Estudos Retrospectivos , Taxa de Sobrevida/tendências , Tuberculose/prevenção & controle
5.
Indian J Tuberc ; 55(3): 122-6, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18807743

RESUMO

BACKGROUND: Drug abuse is on the rise. Drug addiction lowers the general immunity of the body. Tuberculosis is known to be one of the major infectious diseases with a high incidence among drug addicts. Treatment of drug addicts suffering from tuberculosis is a challenge to the treating physician. METHODS: An interventional prospective study which involved free de-addiction drugs and motivation along with free anti tubercular drugs under Revised National Tuberculosis Programme was undertaken among drug addicts. Sixty drug addicts suffering from tuberculosis, registered under RNTCP in SPM marg TB Clinic (Pili Kothi) between 2002-2007 and treated under DOTS along with de-addiction treatment by an NGO (Sharan) formed the study sample. OBJECTIVES: Objectives of the study were: a) To study the profile of drug addicts with tuberculosis, b) To assess the success results of DOTS in drug addicts with tuberculosis (along with de-addiction treatment). RESULTS: Extensive counselling for de-addiction and motivation of the study patients along with nutritional food supplements improved the compliance and adherence to treatment with equal success rates as in non-addict tuberculosis patients. The overall success rate in drug addicts was 83.3%. The default rate of 3.3% and failure rate of just 1.7% among study group were also within the permissible range of RNTCP (< 4%). CONCLUSION: DOTS along with supplementary intervention was observed to be quite effective in drug addicts with TB.


Assuntos
Terapia Diretamente Observada , Usuários de Drogas , Tuberculose/tratamento farmacológico , Adolescente , Adulto , Antituberculosos/uso terapêutico , Buprenorfina/uso terapêutico , Humanos , Índia , Masculino , Pessoa de Meia-Idade , Motivação , Antagonistas de Entorpecentes/uso terapêutico , Cooperação do Paciente , Estudos Prospectivos , Transtornos Relacionados ao Uso de Substâncias/tratamento farmacológico , Resultado do Tratamento , Adulto Jovem
7.
J Commun Dis ; 36(4): 251-9, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16506547

RESUMO

A total of 8.37% of the 1195 patients treated at NDTB Centre with DOTS under RNTCP between January 2002 to June 2003 presented with adverse drug reactions. Patients showing any sort of adverse reactions were studied in detail by personal interviews and a semi-structured questionnaire. The profile of patients presenting with adverse reactions showed that majority of the patients (53%) had gastrointestinal reactions, the commonest presenting complaint being nausea and vomiting. General aches and pains were complained by about 35% and giddiness was the presenting complaint in 27% irrespective of the use of streptomycin, although giddiness was observed more often in Category II patients (59%). Skin rash and itching was complained by about 17% of patients and 11% complained of arthralgia, while only 1% had hepatotoxicity during treatment. Majority of the adverse reactions (67%) were observed within the first four weeks of treatment and only 0.25% of patients treated with DOTS had interruption of treatment for short periods.


Assuntos
Antituberculosos/efeitos adversos , Terapia Diretamente Observada , Tuberculose/tratamento farmacológico , Adolescente , Adulto , Antituberculosos/administração & dosagem , Antituberculosos/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada , Etambutol/administração & dosagem , Etambutol/efeitos adversos , Etambutol/uso terapêutico , Feminino , Humanos , Índia , Isoniazida/administração & dosagem , Isoniazida/efeitos adversos , Isoniazida/uso terapêutico , Masculino , Pessoa de Meia-Idade , Programas Nacionais de Saúde , Cooperação do Paciente , Pirazinamida/administração & dosagem , Pirazinamida/efeitos adversos , Pirazinamida/uso terapêutico , Rifampina/administração & dosagem , Rifampina/efeitos adversos , Rifampina/uso terapêutico , Estreptomicina/administração & dosagem , Estreptomicina/efeitos adversos , Estreptomicina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...